Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene

Biochem Biophys Res Commun. 2000 Jul 14;273(3):1008-14. doi: 10.1006/bbrc.2000.3079.

Abstract

Glucocorticoid hormones are potent antiinflammatory drugs. A key mechanism in the antiinflammatory action is repression of the nuclear factor kappa B (NF-kappaB) signaling pathway. This results in transcriptional repression of inflammatory genes controlled by NF-kappaB, including the intercellular adhesion molecule-1 (ICAM-1). We have investigated expression levels, nuclear translocation and DNA binding of NF-kappaB in vitro and in vivo in U937 cells during activation and repression. Repression of NF-kappaB signaling by glucocorticoids does not prevent NF-kappaB translocation or DNA binding. However interestingly, in vivo foot printing of the NF-kappaB site in the ICAM-1 gene indicates that glucocorticoids change the conformation of the protein complex binding to the NF-kappaB site. These results suggests that NF-kappaB interaction with the glucocorticoid receptor does not displace NF-kappaB from its DNA binding site but rather changes the complex into a transcriptionally inert form.

MeSH terms

  • Base Sequence
  • Cell Nucleus / metabolism
  • DNA Footprinting
  • DNA Primers
  • DNA-Binding Proteins / metabolism
  • Glucocorticoids / pharmacology*
  • Humans
  • I-kappa B Proteins*
  • Intercellular Adhesion Molecule-1 / genetics*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • Promoter Regions, Genetic
  • Protein Binding
  • Receptors, Glucocorticoid / metabolism
  • Transcription, Genetic / drug effects*
  • U937 Cells

Substances

  • DNA Primers
  • DNA-Binding Proteins
  • Glucocorticoids
  • I-kappa B Proteins
  • NF-kappa B
  • NFKBIA protein, human
  • Receptors, Glucocorticoid
  • Intercellular Adhesion Molecule-1
  • NF-KappaB Inhibitor alpha